This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glenn, G. M.
Right arrow Articles by Danielsen, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glenn, G. M.
Right arrow Articles by Danielsen, E. M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2009, p. 5206-5215, Vol. 77, No. 12
0019-9567/09/$08.00+0     doi:10.1128/IAI.00712-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

MINIREVIEW

Toxin-Mediated Effects on the Innate Mucosal Defenses: Implications for Enteric Vaccines {triangledown}

Gregory M. Glenn,1* David H. Francis,2 and E. Michael Danielsen3

Intercell USA, Inc., Gaithersburg, Maryland,1 South Dakota State University, Brookings, South Dakota,2 The Panum Institute, Department of Cellular and Molecular Medicine, Copenhagen, Denmark3

Recent studies have confirmed older observations that the enterotoxins enhance enteric bacterial colonization and pathogenicity. How and why this happens remains unknown at this time. It appears that toxins such as the heat-labile enterotoxin (LT) from Escherichia coli can help overcome the innate mucosal barrier as a key step in enteric pathogen survival. We review key observations relevant to the roles of LT and cholera toxin in protective immunity and the effects of these toxins on innate mucosal defenses. We suggest either that toxin-mediated fluid secretion mechanically disrupts the mucus layer or that toxins interfere with innate mucosal defenses by other means. Such a breach gives pathogens access to the enterocyte, leading to binding and pathogenicity by enterotoxigenic E. coli (ETEC) and other organisms. Given the common exposure to LT+ ETEC by humans visiting or residing in regions of endemicity, barrier disruption should frequently render the gut vulnerable to ETEC and other enteric infections. Conversely, toxin immunity would be expected to block this process by protecting the innate mucosal barrier. Years ago, Peltola et al. (Lancet 338:1285-1289, 1991) observed unexpectedly broad protective effects against LT+ ETEC and mixed infections when using a toxin-based enteric vaccine. If toxins truly exert barrier-disruptive effects as a key step in pathogenesis, then a return to classic toxin-based vaccine strategies for enteric disease is warranted and can be expected to have unexpectedly broad protective effects.


* Corresponding author. Mailing address: Intercell USA Inc., 20 Firstfield Road, Gaithersburg, MD 20878. Phone: (301) 556-4539. Fax: (301) 556-4501: E-mail: gglenn{at}intercell.com

{triangledown} Published ahead of print on 8 September 2009.

Editor: J. B. Kaper


Infection and Immunity, December 2009, p. 5206-5215, Vol. 77, No. 12
0019-9567/09/$08.00+0     doi:10.1128/IAI.00712-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Chowdhury, F., Begum, Y. A., Alam, M. M., Khan, A. I., Ahmed, T., Bhuiyan, M. S., Harris, J. B., LaRocque, R. C., Faruque, A. S. G., Endtz, H., Ryan, E. T., Cravioto, A., Svennerholm, A. M., Calderwood, S. B., Qadri, F. (2010). Concomitant Enterotoxigenic Escherichia coli Infection Induces Increased Immune Responses to Vibrio cholerae O1 Antigens in Patients with Cholera in Bangladesh. Infect. Immun. 78: 2117-2124 [Abstract] [Full Text]  
  • Moen, S. T., Blumentritt, C. A., Slater, T. M., Patel, S. D., Tutt, C. B., Estrella-Jimenez, M. E., Pawlik, J., Sower, L., Popov, V. L., Schein, C. H., Gilbertson, S. R., Peterson, J. W., Torres, A. G. (2010). Testing the Efficacy and Toxicity of Adenylyl Cyclase Inhibitors against Enteric Pathogens Using In Vitro and In Vivo Models of Infection. Infect. Immun. 78: 1740-1749 [Abstract] [Full Text]